(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Clinical trial NCT05236634 · UNKNOWN

Trial details

NCT number: NCT05236634
Sponsor: Assiut University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2022-05-01
Primary completion: 2024-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.